Literature DB >> 19253481

Making sensible rationing: the use of economic evidence and the need for methodological standards.

Viroj Tangcharoensathien1, Pirom Kamolratanakul.   

Abstract

Thailand was increasingly facing budget constraints when a comprehensive package of services was provided literally free to the whole population; therefore rationing is inevitable. 'Good value for money' is among the popular criteria in priority setting as it offers a sensible basis to compare marginal benefits with the resources spent across interventions. The majority of cost-outcome studies in Thailand were subject to bias as they relied on low-quality evidence. The methods applied also varied greatly. This hampers comparisons across studies. The first ever national guideline was developed by experts from different institutes to propose the most practical ways of conducting health technology assessment on the basis of economic principles in the Thai context. This paper also draws lessons from a transparent process involving key stakeholders in selecting technologies to be assessed given time and resources constraints. Finally, it is hoped that these tools and methods will be applicable for Thailand to facilitate comparisons of different studies in order to better inform policy decisions in a transparent manner

Mesh:

Year:  2008        PMID: 19253481

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  3 in total

Review 1.  Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.

Authors:  Sripen Tantivess; Yot Teerawattananon; Anne Mills
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

2.  The future of health technology assessment in healthcare decision making in Asia.

Authors:  Bong-Min Yang
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  Achieving universal health coverage goals in Thailand: the vital role of strategic purchasing.

Authors:  Viroj Tangcharoensathien; Supon Limwattananon; Walaiporn Patcharanarumol; Jadej Thammatacharee; Pongpisut Jongudomsuk; Supakit Sirilak
Journal:  Health Policy Plan       Date:  2014-11-05       Impact factor: 3.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.